Merck's cholesterol drug meets main goal in late-stage studies - TradingView

Reuters | June 9, 2025, 6:52 a.m. | Original
Merck's cholesterol drug meets main goal in late-stage studies TradingView
Singapore's Grab not in talks with GoTo over a buyout - TradingView Insurtech company Slide targets a $2 billion plus valuation in US IPO - TradingView